Cargando…
Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
In light of the intriguing potential of anti-angiogenic approach in suppressing choroidal neovascularization, we attempted to elaborate synthetic gene delivery systems encapsulating anti-angiogenic plasmid DNA as alternatives of clinical antibody-based therapeutics. Herein, block copolymer of cyclic...
Autores principales: | Wang, Jing, Shi, Xiang, Bo, Qiyu, Wang, Hong, Wei, Fang, Liu, Jun, Wang, Hao, Zhang, Liuwei, Qi, Yan, Li, Zhen, Chen, Qixian, Sun, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609386/ https://www.ncbi.nlm.nih.gov/pubmed/34849167 http://dx.doi.org/10.1016/j.ajps.2021.04.001 |
Ejemplares similares
-
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
por: Wang, Yusong, et al.
Publicado: (2022) -
Alterations in Faecal and Serum Metabolic Profiles in Patients with Neovascular Age-Related Macular Degeneration
por: Yuan, Qixian, et al.
Publicado: (2023) -
Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017) -
Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
por: Choi, Wonmin, et al.
Publicado: (2023) -
Profile of conbercept in the treatment of neovascular age-related macular degeneration
por: Lu, Xinmin, et al.
Publicado: (2015)